How much does stem cell therapy for Liver Cirrhosis cost? (2026)
The comparison dataset stores a Bulgaria planning observation of €3,000–€8,000 for treatment, compiled from cited public commercial sources. It is not a quotation from Stem Plus, and different products, doses, visits and inclusions must not be treated as equivalent. The stored registry query contains 89 Liver Cirrhosis records. Registration does not mean that a study is recruiting, that a person is eligible, or that treatment and travel are free; verify the current record and sponsor-cost terms directly.
Cirrhosis is advanced liver scarring caused by different diseases and can lead to portal hypertension, infection, encephalopathy, cancer and liver failure. Cell proposals aim to influence inflammation or regeneration, but a laboratory mechanism does not show reversal of established fibrosis or restored liver function. Product source, processing, route and disease cause matter.
What drives the cost for Liver Cirrhosis
An itemised estimate should separate research product, admission, imaging, laboratory monitoring, treatment of ascites or infection, travel, follow-up and emergency or transplant care. Do not treat a commercial infusion price as an alternative to specialist hepatology and transplant planning.
Cell studies remain investigational and heterogeneous; changes in laboratory values must not be equated with survival, fewer decompensations or avoidance of transplantation. The NIDDK cirrhosis treatment guide emphasises treating the cause and complications, surveillance and liver-transplant assessment for liver failure. Experimental access should occur only through a verified protocol without delaying those measures.
Liver Cirrhosis cost by country — comparison (2026)
| Location | Indicative treatment cost | Regulation |
|---|---|---|
| Bulgaria (EU) · e.g. Stem Plus | €3,000–€8,000 | Verify provider and laboratory certificates |
| USA | €4,600–€46,000 | Non-EU; verify provider and product status |
| UK | €4,880–€49,000 | Non-EU; verify provider and product status |
| Germany | €11,000–€36,700 | EU member state; verify provider and product status |
| Switzerland | €20,000–€40,000 | Non-EU; verify provider and product status |
| Mexico | €3,000–€12,000 | Non-EU; verify provider and product status |
| India | €3,000–€8,000 | Non-EU; verify provider and product status |
| Serbia | €7,000–€31,000 | Non-EU; verify provider and product status |
| Turkey | €6,000–€18,000 | Non-EU; verify provider and product status |
| Thailand | €8,000–€20,000 | Non-EU; verify provider and product status |
| Panama | €15,000–€27,000 | Non-EU; verify provider and product status |
Price varies with cell type, dose, number of sessions, diagnostics, supportive care and follow-up. A lower range does not establish equivalent quality or outcome. Request a fixed written quote and verify the therapy and provider with the relevant authorities. Check registered trials before paying privately.
Liver Cirrhosis cost — common questions
Why is Liver Cirrhosis stem-cell treatment so much cheaper in Bulgaria?
The collected commercial ranges differ, but they may describe different products, doses, visits and inclusions. A lower quote does not establish equivalent quality, evidence or regulatory status.
Is a cheaper programme riskier?
Price alone cannot establish risk. Verify the exact treatment status, provider and manufacturing authorisations, product identity, release testing, adverse-event plan and primary evidence.
Does the price include travel and hotel?
The €3,000–€8,000 range covers the medical programme. Add flights, hotel and recovery with our calculator for your true all-in cost from your city.
Will I get a fixed quote, or an open-ended bill?
Ask for a written quotation after clinical review, with the exact product, inclusions, exclusions, cancellation terms and circumstances in which charges may change. A website estimate is not a binding quote.
Sources & further reading
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
- Open clinical trials for Liver Cirrhosis (ClinicalTrials.gov) ↗
- Peer-reviewed research on PubMed ↗
- ISSCR patient guide — what to ask ↗
- FDA consumer warning on stem-cell therapies ↗
- EMA — advanced-therapy (ATMP) framework ↗
- Clinic perspective — Stem Plus on Liver Cirrhosis ↗
Indicative ranges for planning, compiled from public market data; confirmed pricing follows a medical review. Not medical advice.